Neurogene (NGNE) Change in Cash (2013 - 2026)

Neurogene has reported Change in Cash for 14 years, with the latest figure at $20.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 130.87% year-over-year to $20.3 million; the trailing twelve-month figure through Mar 2026 stood at $53.4 million (up 167.27% YoY), and the FY2025 full-year result was -$32.7 million, down 177.63% from the prior year.
• Change in Cash for Q1 2026 stood at $20.3 million, down from $32.8 million in the prior quarter.
• The five-year high for Change in Cash was $113.6 million in Q4 2022, with the low at -$65.8 million in Q1 2025.
• Historically, Change in Cash has averaged $3.2 million across 5 years, with a median of -$12.0 million in 2025.
• Annual changes were most pronounced in 2022 — Change in Cash surged 1012.01% — and 2025, when it plunged 3837.37%.
• Neurogene's Change in Cash stood at $113.6 million in 2022, then fell by 9.2% to $103.2 million in 2023, then plunged by 32.19% to $70.0 million in 2024, then sank by 53.05% to $32.8 million in 2025, then slumped by 38.14% to $20.3 million in 2026.
• The last three Change in Cash figures came in at $20.3 million (Q1 2026), $32.8 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.